Jacobs Levy Equity Management’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $632K | Sell |
441,735
-255,918
| -37% | -$366K | ﹤0.01% | 840 |
|
|
2025
Q1 | $1.12M | Buy |
+697,653
| New | +$1.12M | ﹤0.01% | 791 |
|
|
2024
Q1 | – | Sell |
-100,370
| Closed | -$567K | – | 948 |
|
|
2023
Q4 | $567K | Sell |
100,370
-764,111
| -88% | -$4.32M | ﹤0.01% | 810 |
|
|
2023
Q3 | $1.61M | Buy |
864,481
+135,540
| +19% | +$252K | 0.01% | 599 |
|
|
2023
Q2 | $2M | Buy |
728,941
+5,240
| +0.7% | +$14.4K | 0.01% | 565 |
|
|
2023
Q1 | $2.27M | Sell |
723,701
-4,970
| -0.7% | -$15.6K | 0.01% | 549 |
|
|
2022
Q4 | $4.3M | Sell |
728,671
-10,322
| -1% | -$60.9K | 0.03% | 423 |
|
|
2022
Q3 | $6.48M | Buy |
738,993
+206,573
| +39% | +$1.81M | 0.05% | 337 |
|
|
2022
Q2 | $4.01M | Buy |
+532,420
| New | +$4.01M | 0.03% | 458 |
|
|
2021
Q3 | – | Sell |
-23,413
| Closed | -$886K | – | 1043 |
|
|
2021
Q2 | $886K | Buy |
+23,413
| New | +$886K | 0.01% | 762 |
|